Castelein H, Declercq P E, Mannaerts G P, Baes M I
Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Catholic University of Leuven, Belgium.
FEBS Lett. 1993 Oct 11;332(1-2):24-6. doi: 10.1016/0014-5793(93)80474-9.
Peroxisome proliferators and thyroid hormones have a number of common metabolic effects. The possibility that the signal transduction pathways of both groups of effectors converge at the receptor level was investigated. It was shown that T3, specifically bound to the rat thyroid beta-receptor, was not displaced to a significant extent by ciprofibrate or bezafibrate. No specific binding of T3 to the mouse peroxisome proliferator activated receptor could be demonstrated. In transactivation experiments peroxisome proliferators were unable to activate the thyroid receptor and T3 did not activate a chimeric receptor containing the ligand binding domain of the peroxisome proliferator activated receptor. It is concluded that peroxisome proliferators and thyroid hormone do not cross-react at the level of their nuclear receptors.
过氧化物酶体增殖剂和甲状腺激素具有许多共同的代谢效应。研究了这两组效应物的信号转导途径在受体水平上汇聚的可能性。结果表明,特异性结合大鼠甲状腺β受体的T3不会被环丙贝特或苯扎贝特显著取代。未证明T3与小鼠过氧化物酶体增殖物激活受体有特异性结合。在反式激活实验中,过氧化物酶体增殖剂无法激活甲状腺受体,T3也不能激活含有过氧化物酶体增殖物激活受体配体结合域的嵌合受体。结论是过氧化物酶体增殖剂和甲状腺激素在其核受体水平上不会发生交叉反应。